Article

Sydney Morning Herald on 2021-10-12 04:49

CSL rules out making homegrown mRNA COVID vaccine

The local biotech giant’s boss, Paul Perreault, says mRNA technology will be used to develop a treatment against flu instead of COVID-19, with trials ...

Related news

Startups join CSL, Moderna in local mRNA vaccine manufacturing push Sydney Morning Herald
The Market , Melbourne , Sydney , Australia , Australia
‘Competitive advantage’: New flu vaccine research a focus for CSL Sydney Morning Herald
California , Germany , Parkville , Australia , Melbourne
‘Not for the faint of heart’: CSL interested in mRNA development Sydney Morning Herald
Pacific Ocean , Asia , Australia , Australia , Melbourne
‘Not helpful’: Tough border rules cause Mexico headache for CSL Sydney Morning Herald
The Market , Australia , United States , Mexico
Melbourne biotech to make mRNA vaccine in Australia Sydney Morning Herald
The Market , Australia , Melbourne
Pfizer, CSL coy on mRNA push in Australia Sydney Morning Herald
Europe , North America , Australia
Vaccine boost fails to ignite CSL shares Sydney Morning Herald
Australia , Australia , Melbourne
Government calls for pitches for mRNA vaccine production facilities Sydney Morning Herald
Melbourne , Parkville , Melbourne International Airport , United States , Singapore
HAustralia Won’t Rush Pfizer After Homegrown Vaccine Canned hamodia.com
South Australia , Canberra , Western Australia , Queensland , Melbourne
Australia won’t rush Pfizer after homegrown vaccine canned staradvertiser.com
South Australia , Canberra , Western Australia , Queensland , Melbourne
‘Large disruptor’: Moderna’s promise of vaccine ‘cocktail’ could be headache for CSL Sydney Morning Herald
The Market , Australia , Melbourne , Australia
'Be prepared for anything': CSL boss warns of key unknowns on vaccine Sydney Morning Herald
Australia , Oxford , Australia
CSL profits jump 44 per cent on vaccine demand in the pandemic Sydney Morning Herald
Australia , Melbourne
CSL shelves UQ vaccine plans, says outcome highlights 'risk of failure' with early development Sydney Morning Herald
Phase 1 , Melbourne
Morrison faces internal pressure over mRNA vaccine manufacturing Sydney Morning Herald
Australia , China , South Korea , Singapore , Americas
Government confident CSL can produce enough vaccine for entire population Sydney Morning Herald
United Kingdom , Australia , Australia
CSL stays 'fully focused' on AstraZeneca vaccine despite scientist concerns Sydney Morning Herald
Mexico , Parkville , Sydney , Australia
‘Unintended consequences’: CSL, biotechs warn against vaccine IP waiver Sydney Morning Herald
The Market , United States , Sydney Olympic Park , Australia